CITADEL ADVISORS LLC

Holdings History for Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA)

Symbol
LYRA on Nasdaq
Investment type
Equity / Common Stock, $0.001 par value
Latest Disclosed Shares Owned
0 shares
Security Ownership %
0%
Shares, Excluding Options vs Price
Value, Excluding Options

Citadel Advisors LLC ownership in Lyra Therapeutics, Inc. Common Stock, $0.001 par value (LYRA)

14 Feb 2025 - Citadel Advisors LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Lyra Therapeutics, Inc. Common Stock, $0.001 par value (LYRA). This represents 0% ownership of the company. This is the first filing by CITADEL ADVISORS LLC disclosing ownership of Lyra Therapeutics, Inc. Common Stock, $0.001 par value (LYRA).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.